Translational Health Research Into Vascular and Neurocognitive Effects of Weight Loss

NCT07592546 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

240

Enrollment

OTHER

Sponsor class

Conditions

Class I/II Obesity

Interventions

DRUG: semaglutide

Sponsor

Alain Dagher